Intel and Samsung Medison Collaborate on Obstetrics and Gynecology Ultrasound Technology
Development of measurement solutions used in over 80 countries


According to the World Health Organization (WHO), approximately 295,000 women died during pregnancy and childbirth in 2017 alone. The UK's Perinatal Institute stated that tracking fetal growth is effective in protecting mothers and preventing stillbirths.

Intel announced on the 15th that it is developing a measurement solution to ensure the safety of mothers and fetuses together with Samsung Medison.

Samsung Medison’s BiometryAssist™ is equipped with an Intel Core i3 processor, Intel® Distribution of OpenVINO™ toolkit, and OpenCV toolkit, enabling it to automatically and easily measure the growth status of a fetus with 97% accuracy in just 85 ms (milliseconds).

In addition, LaborAssist™ automatically measures the Angle of Motion (AoP) during labor, allowing doctors to assess the rate of fetal development. This supports doctors in determining the optimal delivery method and can reduce unnecessary Cesarean sections.

The two measurement solutions are used in over 80 countries around the world, including Korea, the United States, Italy, France, Brazil, and Russia. It also received approval from the U.S. Food and Drug Administration (FDA) in 2020.

Both companies plan to continue collaborating on the development of technologies related to Samsung Medison's next-generation ultrasound solutions, including nerve tracking, SW beamforming, and AI modules.